NeurologyHumansPipecolic AcidsEptifibatideMaleFemale
Thrombolysis Alone vs With Argatroban or Eptifibatide: A Prespecified Subgroup Analysis of the MOST Trial.
Akash Roy, Jordan Elm, James R Ingles, Noor Sabagha, Josephine F Huang, Oladi Bentho, Tamra Ranasinghe, Christopher Streib, Mauricio Concha, Pooja Khatri, Achala Vagal, Max Wintermark, Colin P Derdeyn, Joseph P Broderick, Andrew D Barreto
Published: 202510.1212/WNL.0000000000214228
Abstract
BACKGROUND AND OBJECTIVES: IV thrombolysis only (IVT-O) is the primary reperfusion therapy for most stroke patients. At least 50% of IVT-O patients remain disabled. We assessed 2 therapies added to IVT-O aimed at increasing clot lysis or preventing a…
Preview only. Read the full abstract at the source